Skip to main content

Table 3 Comparison of general characteristics and operative information between patients with micro- and macro- medullary thyroid carcinoma

From: Clinicopathological characteristics and prognosis of medullary thyroid microcarcinoma: a tumor with a similar prognosis to macrocarcinoma

 

Micro (n = 56)

Macro (n = 142)

p

Male/female (n)

27/29

60/82

0.447

Age (years)

46.9 ± 12.1

47.7 ± 12.8

0.693

BMI (kg/m2)

23.3 ± 3.4

23.8 ± 3.5

0.390

Hereditary (n)

8

24

0.652

Hashimoto's disease (n)

9

24

0.888

Calcitonin ˃10 pg/mL (n)

32

94

0.233

CEA ˃5 ng/mL (n)

21

83

0.008

FT3 (pg/mL)

3.1 ± 0.4

3.1 ± 0.5

0.594

FT4 (ng/dL)

1.3 ± 1.0

1.3 ± 0.9

0.997

Sonographic features (n)

 Spiculated margin

41

87

0.113

 Microcalcification

30

73

0.784

 Hypervascularity

41

101

0.769

ASA ≥ III (n)

0

6

0.187

Operative time (min)

105 (80, 169)

135 (100, 180)

0.029

Postoperative complications (n)

5

18

0.459

Central LNM (n)

22

76

0.071

Lateral LND (n)

23

87

0.010

Lateral LNM (n)

16

66

0.021

  1. BMI body mass index, CEA carcinoembryonic antigen, FT3 free triiodothyronine, FT4 free thyroxine, ASA American Society of Anesthesiologists, LNM lymph node metastasis, LND lymph node dissection